SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-008664
Filing Date
2023-03-17
Accepted
2023-03-17 17:20:50
Documents
13
Period of Report
2023-03-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gern-20230317.htm   iXBRL 8-K 68944
2 NOTICE OF PENDENCY OF SETTLEMENT OF DERIVATIVE LITIGATION gern-ex99_2.htm EX-99 118220
  Complete submission text file 0000950170-23-008664.txt   384417

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20230317_pre.xml EX-101.PRE 26218
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20230317.xsd EX-101.SCH 2561
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20230317_lab.xml EX-101.LAB 32471
7 EXTRACTED XBRL INSTANCE DOCUMENT gern-20230317_htm.xml XML 4701
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 23743879
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences